Skip to main content
. 2019 May 13;7(2):21. doi: 10.3390/proteomes7020021

Table 1.

The proteomic studies on melanoma-derived EVs (or secretome).

Source of EVs Types of Isolated EVs Methods of Isolation Applied Proteomic Techniques Number of Identified Proteins Major Findings Ref.
MeWo and SK-MEL-28 human melanoma cell lines exosomes 0.1 µm filtration followed by ultracentrifugation at 100,000× g 2D SDS-PAGE-MS/MS (MALDI-TOF) Forty-nine common protein spots in the exosome samples corresponding to 41 different proteins p120 catenin, radixin, and immunoglobulin superfamily member 8 were identified in exosomes for the first time; mitochondrial and lysosomal proteins were significantly reduced in exosomes, confirming the endosomal origin of exosomes [26]
MNT-1, G1 and Mel501 (non-tumorigenic), Daju and SK-MEL-28 (tumorigenic), A375 and 1205Lu (metastatic) human melanoma cell lines exosomes ultracentrifugation (100,000× g) and separation in sucrose (0.25–2.5 M) density gradient 1D SDS-PAGE followed by nano LC-MS/MS between 486 and 632 depending on the cell line (517 on average); 917 unique proteins in all samples exosomes from aggressive cells contained specific proteins involved in cell motility, angiogenesis, and immune response that were less-abundant or absent in exosomes from less-aggressive cells [28]
Mel501 human melanoma cell line cultured in standard or acidic (pH 6.0) conditions exosomes ultracentrifugation (130,000× g) and separation in iodixanol (OptiPrep) gradient 1D SDS-PAGE followed by RPLC-MS/MS three replicates for exosomes from pH 6.0: 212, 211, and 217 proteins; control: 194, 239, and 130 proteins lower pH 6.0 modified exosome protein profile, causing up-regulation of more than 50% of the proteins [30]
B16-F1 melanoma cell line (established from C57BL/6 mouse) exosomes, ectosomes, apoptotic bodies centrifugation at 25,000× g to pellet ectosomes and apoptotic bodies; the remaining supernatant was then filtered (0.22 μm) and exosomes were pelleted at 100,000× g; exosomes and apoptotic bodies were further purified by discontinuous sucrose cushion or linear sucrose gradient, respectively uHPLC-MS (nanospray source of a LTQ Orbitrap XL) 553 proteins common to all populations procoagulant proteins were more abundant in ectosomes and apoptotic bodies than in exosomes, with tissue factor (and lipid-phosphatidylserine) critical for procoagulant activity [24]
B16F10 mouse melanoma cell line exosomes, ectosomes 10,000× g to pellet ectosomes; exosomes were then pelleted from the remaining supernatant at 110,000× g; sucrose density and Nycodenz gradients were also applied to further separate exosomes; independent isolation of exosomes was performed using size exclusion chromatography (SEC) nanoLC-MS/MS a total of 4421 proteins; 1540 proteins common to all populations, and 533, 354, and 110 proteins were identified exclusively in ectosomes and low- and high-density exosomes, respectively bottom-loading (instead of top-loading) of exosomes on sucrose density and Nycodenz gradients resulted in separation of high- and low-density exosomes displaying distinct protein profiles [29]
melanoma A375 and normal melanocytic HEMa-LP cell lines exosomes 500 kDa cut-off ultrafiltration followed by ultracentrifugation at 100,000× g, Exoquick-TC precipitation 2D DIGE-LC-MS/MS total number not provided, 114 protein spots detected differential expression of annexin A1, annexin A2, syntenin-1, and hyaluronian and proteoglycan link protein 1 between melanocytes and melanoma exosomes [27]
primary cell cultures established from 14 original tumor specimens of uveal melanoma patients not isolated, entire secretome was analyzed - label-free nanoLC-MS/MS total of 1843 proteins (758 with at least 3 unique peptides) a subsets of 83 up-regulated and 80 down-regulated proteins in uveal melanoma secretome [38]
sera of uveal melanoma patients and healthy controls not isolated, entire secretome was analyzed - 2D SDS-PAGE- LS-MS (CapLC system coupled to a Q-TOF spectrometer) 133 (on average) cathepsin D and gp100 protein levels increased in sera of uveal melanoma patients [25]